Drug Shortage Report for AZITHROMYCIN FOR INJECTION, USP

Last updated on 2025-07-10 History
Report ID 257694
Drug Identification Number 02531429
Brand name AZITHROMYCIN FOR INJECTION, USP
Common or Proper name AZITHROMYCIN FOR INJECTION, USP
Company Name EUGIA PHARMA INC.
Market Status MARKETED
Active Ingredient(s) AZITHROMYCIN
Strength(s) 500MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 10
ATC code J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2025-05-15
Estimated end date 2025-12-31
Actual end date
Shortage status Actual shortage
Updated date 2025-07-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2025-07-10 French Compare
v5 2025-07-10 English Compare
v4 2025-07-10 French Compare
v3 2025-07-10 English Compare
v2 2025-05-16 French Compare
v1 2025-05-16 English Compare

Showing 1 to 6 of 6